![]() 2-Bromo-4'-chloroacetophenone structure
|
Common Name | 2-Bromo-4'-chloroacetophenone | ||
---|---|---|---|---|
CAS Number | 536-38-9 | Molecular Weight | 233.490 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 289.7±15.0 °C at 760 mmHg | |
Molecular Formula | C8H6BrClO | Melting Point | 95-99ºC | |
MSDS | Chinese USA | Flash Point | 129.0±20.4 °C | |
Symbol |
![]() GHS05 |
Signal Word | Danger |
Name | 2-Bromo-4’-chloroacetophenone |
---|---|
Synonym | More Synonyms |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 289.7±15.0 °C at 760 mmHg |
Melting Point | 95-99ºC |
Molecular Formula | C8H6BrClO |
Molecular Weight | 233.490 |
Flash Point | 129.0±20.4 °C |
Exact Mass | 231.929047 |
PSA | 17.07000 |
LogP | 2.88 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.584 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C:Corrosive; |
Risk Phrases | R22;R34 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 3261 8/PG 2 |
WGK Germany | 2 |
RTECS | AM5978800 |
Packaging Group | III |
HS Code | 2914399090 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2914399090 |
---|---|
Summary | 2914399090. other aromatic ketones without other oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs.
J. Enzyme Inhib. Med. Chem. 29(6) , 846-67, (2014) Because of the pivotal role of cyclooxygenase (COX) in the inflammatory processes, non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatme... |
|
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
J. Med. Chem. 54 , 4042-56, (2011) Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, bein... |
α-Bromo-p-chloroacetophenone |
MFCD00000625 |
Ethanone, 2-bromo-1-(4-chlorophenyl)- |
ω-Bromo-4-chloroacetophenone |
2-Bromo-4‘-chloroacetophenone |
2-Bromo-4'-chloroacetophenone |
α-Bromo-4-chloroacetophenone |
4'-Chloro-2-Bromoacetophenone |
4-Chlorophenacyl Bromide |
EINECS 208-631-5 |
2-Bromo-1-(4-chlorophenyl)ethanone |
Ethanone, 2-bromo-1- (4-chlorophenyl)- |
α-Bromo-4'-chloroacetophenone |
2-bromo-1-(4-chlorophenyl)ethan-1-one |